Keith Zullow

ID: 1b83dce7-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Celltrion and Rani Therapeutics to Jointly Develop Oral Formulation of Adalimumab Biosimilar

Big Molecule Watch · June 21, 2023

Alvotech and Teva Reach Ustekinumab (STELARA) Settlement with J&J

Big Molecule Watch · June 13, 2023

Janssen and Amgen Settle STELARA (Ustekinumab) BPCIA Litigation

Big Molecule Watch · May 23, 2023

REMICADE Antitrust Settlement Receives Final Approval

Big Molecule Watch · April 12, 2023

Alteogen and Sandoz Enter a Biosimilars Agreement Relating to Subcutaneous Products

Big Molecule Watch · February 27, 2023